Journals / Retina-Vitreus / 2022 / Cilt: 31 - Sayı: 2

Comparison of Ranibizumab and Aflibercept Effects on Inner Retinal Layers in Neovascular Age-Related Macular Degeneration

Pages
111–117
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Ganglion cell layer thinning was significant at the end of 3 months, thinning of the inner nuclear layer was significant at the end of one year in both groups (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the changes of all inner retinal layers in eyes with neovascular age-related macular degeneration (nAMD) during anti- vascular endothelial growth factor (anti-VEGF) treatments and to compare two different anti-VEGF agents; ranibizumab and aflibercept.
📊
Key Findings & Data:Materials and Methods: This retrospective, comparative study comprised 40 treatment-naive eyes of 40 patients treated with ranibizumab (20 eyes) or aflibercept (20 eyes) injections for nAMD.
💡
Conclusion & Impact:Ganglion cell layer thinning was significant at the end of 3 months, thinning of the inner nuclear layer was significant at the end of one year in both groups (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To evaluate the changes of all inner retinal layers in eyes with neovascular age-related macular degeneration (nAMD) during anti- vascular endothelial growth factor (anti-VEGF) treatments and to compare two different anti-VEGF agents; ranibizumab and aflibercept. Materials and Methods: This retrospective, comparative study comprised 40 treatment-naive eyes of 40 patients treated with ranibizumab (20 eyes) or aflibercept (20 eyes) injections for nAMD. Thicknesses of the total retina and inner retinal layers were measured by spectral-domain OCT in the central 1-mm diameter and surrounding 3-mm diameter rings of Early Treatment Diabetic Retinopathy Study grid. Changes in each layer and comparison between ranibizumab and aflibercept groups were analyzed statistically during 1-year follow-up. Results: The ranibizumab group showed 3.85±16.54 letters of increase and the aflibercept group showed 4.20±16.30 letters of increase at the end of 1 year. There was a significant decrease in total retinal thickness in both groups at the end of 1 year (p=0.006 in ranibizumab, p=0.005 in aflibercept). Ganglion cell layer thinning was significant at the end of 3 months, thinning of the inner nuclear layer was significant at the end of one year in both groups (p

🔖

Cite This Article

Demir, N., Kayhan, B., Sevincli, S., Sonmez, M. (2022). Comparison of Ranibizumab and Aflibercept Effects on Inner Retinal Layers in Neovascular Age-Related Macular Degeneration. Retina-Vitreus, Cilt: 31 - Sayı: 2, 111–117. https://ajindex.com/articles/589036

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Klaver CC, Wolfs RC, Vingerling JR, et al. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 1998; 116: 653-658
  2. Friedman DS, O'Colmain BJ, Muñoz B, et al. Prevalence of age- related macular degeneration in the United States. Eye diseases prevalence research group. Arch Ophthalmol 2004; 122(4): 564- 572
  3. Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2014; 2: 106-116
  4. Hoeben A, Landuyt B, Highley MS, et al. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004; 56(4): 549-580
  5. Shibuya M. Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem 2013; 153(1): 13-19
  6. Solomon SD, Lindsley K, Vedula SS, et al. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev 2019; 3(3): CD005139
  7. Gillies MC, Hunyor AP, Arnold JJ, et al. Effect of ranibizumab and aflibercept on best-corrected visual acuity in treat-and- extend for neovascular age-related macular degeneration: A randomized clinical trial. JAMA Ophthalmol 2019; 137(4): 372- 379
  8. Foxton RH, Finkelstein A, Vijay S, et al. VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma. Am J Pathol 2013; 182(4): 1379-1390
  9. Saint-Geniez M, Maharaj AS, Walshe TE, et al. Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors. PLoS One 2008; 3(11): e3554
  10. Cho HJ, Yoo SG, Kim HS, et al. Risk factors for geographic atrophy after intravitreal ranibizumab injections for retinal angiomatous proliferation. Am J Ophthalmol 2015; 159: 285- 292
  11. Latzer P, Schlegel U and Theiss C. Morphological changes of cortical and hippocampal neurons after treatment with VEGF and bevacizumab. CNS Neurosci Ther 2016; 22(6): 440-450
  12. Park HY, Kim JH and Park CK. Neuronal cell death in the inner retina and the influence of vascular endothelial growth factor inhibition in a diabetic rat model. Am J Pathol 2014; 184(6): 1752-1762
  13. Muftuoglu IK, Ramkumar HL, Bartsch DU, et al. Quantitative analysis of the inner retinal layer thicknesses in age-related macular degeneration using corrected optical coherence tomography se